Celmatix

Looking for a podcast to tune into this weekend? Don't miss the latest episode of Boss Ovary featuring our CEO Dr. Piraye Beim and today's guest, Dr. Aparna (Amy) Divaraniya, PhD, CEO & Founder of Oova! Check out the teaser below and listen to the full episode here: https://lnkd.in/djSMQvib

We are beyond thrilled to see Congress recognize the importance of #OvarianHealth throughout a woman's lifespan in the House Fiscal Year 2025 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations legislation that passed the committee. This milestone is a giant step forward for women's health, unlocking opportunities for research, policy advancements and funding. Our CEO and Founder, Dr. Piraye Beim, has worked as a tireless advocate to educate policy decision-makers on how ovaries impact women’s health far beyond having babies and the transition to #menopause. Years ago, we coined the term "Ovarian Health" to highlight the ovary's impact on #womenshealth. While traditionally associated with just fertility and menopause (even in medical school), the ovary serves a core function essential to the health of the brain, body, and more. Applying this to patient care and health innovation is vital to improving outcomes in everything from maternal health to cardiovascular disease to autoimmune diseases to dementia. Below is the wording that Congress included: Ovarian Health.—The Committee recognizes that ovarian health impacts a woman’s whole health throughout her lifetime, affecting the health of her heart, immune system, metabolic function, among other systems. When ovarian function declines or ceases due to menopause, various medical conditions, or following surgery, women are at increased risks for developing many chronic conditions, including heart disease, osteoporosis, dementia, and autoimmune diseases. Advancing knowledge and research on ovarian health could reduce many of these chronic conditions, especially as women age. Thank you Congress and cheers to women everywhere!   

"Researchers from the UC Berkeley School of Public Health detected toxic metals such as lead, arsenic, and cadmium in both organic and nonorganic tampons. Public Health Berkeley reports that university researchers studied 30 tampons from 14 brands and found 16 metals that could put women at a higher risk of cardiovascular disease, cancer, infertility, and even dementia. As half the world’s population has been menstruating monthly for years with more than half of them, 52-86% using tampons for days, the potential public health concern besides disease is infertility."

Have you listened to the latest episode of the Boss Ovary podcast featuring Dr. David Sable? In this episode, our CEO + Founder, Piraye Beim and Dr. Sable explore the transformative journey of advancements in reproductive health and more! Tune in now to hear the full episode: https://lnkd.in/dTke_DP6

What an unforgettable time at Aspen Ideas Health hosted by The Aspen Institute! Our CEO Piraye Beim was joined by some of our favorite leaders and innovators in healthcare! It was exciting and encouraging to see menopause as a focal point. 👏 Ft: Daniel Kraft, MD, Zubaida Bai Emi Kolawole

About time! Scientists at the University of Michigan have developed the first comprehensive cellular map of a human ovary. This work, described as an atlas, allows researchers to understand the ovary's complex structure and function, paving the way for future treatments. Beyond fertility, this research holds potential for studying ovarian diseases, endocrine functions, and even extending ovarian longevity. The applications are vast, offering hope for patients with infertility issues, cancer survivors, and more. Great read by Mary Brophy Marcus in Medscape:

It's here! Check out the latest episode of the Boss Ovary hosted by our CEO Dr. Piraye Beim & Dr. David Sable! In this discussion, they explore the transformative journey of reproductive health from a medical and technological perspective. Dr. Sable shares his insights on the evolution of healthcare from analog to digital, emphasizing the critical role of data in advancing women's health. He reflects on the past decades of progress in IVF and reproductive technologies, comparing these advancements to other technological revolutions in history. Whether you're a healthcare professional, someone interested in the latest in medical technology, or just curious about the future of women's health, this episode offers profound insights and forward-thinking discussions that promise to inspire and inform! Listen now on Spotify:

Here's a little teaser for the next episode of Boss Ovary hosted by our CEO Dr.Piraye Beim! Don't miss this episode with Dr. David Sable...it drops tomorrow! Dr. David Sable is a true-multihyphenate: a global leader in reproductive medicine, reproductive endocrinology, and IVF, an entrepreneur, a professor, an investor...and so much more! Stay tuned!! #Fertility #ivf #womenshealth #reproductivehealth

"About half of all infertility cases involve male fertility issues. Yet reproductive spaces are often dominated by women — and the male perspective goes unheard." Very interesting episode on "Embodied" hosted by Paige Perez and  Anita Rao North Carolina Public Radio-WUNC:

Our CEO & Founder Piraye Beim spoke on the panel "A conversation at the intersection of women's health and the global economy" hosted by Hinter Media alongside: Elizabeth Garner , former CSO Ferring Pharmaceuticals + Owner, President, KNI Health Consultants Dorothy Gemmell Gemmell / CCO and President of GoodRx Sarah Green, Senior Policy Advisor, Gender Justice and Sexual/Reproductive Health It was an incredible evening filled with thought provoking discussions exploring the issues and intersections defining our contemporary culture.👏